| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/11/1989 | US4847079 Biologically stable interferon compositions comprising thimerosal |
| 07/11/1989 | US4847078 Storage stable topical composition having moisture control agent |
| 07/11/1989 | US4847077 Controlled release pharmaceutical preparations |
| 07/11/1989 | CA1257199A1 Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| 07/11/1989 | CA1257186A1 Assay using at least one peptidic derivative |
| 07/06/1989 | DE3744009A1 Pharmaceutical composition with a neutral flavour and containing one or more amino acids |
| 07/05/1989 | EP0322892A1 Freeze-dried pharmaceutical preparations for parenteral use |
| 07/05/1989 | EP0322568A1 Stabilized delayed release emulsion |
| 07/05/1989 | CN1033624A High potency sweetening agents |
| 07/05/1989 | CN1033568A Pharmacentical composition containing calcitonins and process for preparing same |
| 07/05/1989 | CN1033562A Transdermal absorptive drug formulation |
| 07/04/1989 | US4845200 Antitumor, drug delivery, side effect reduction |
| 07/04/1989 | US4844909 Analgesics |
| 07/04/1989 | US4844893 Antitumor agents |
| 07/04/1989 | US4844826 Use of organosilicon compounds to thicken oils |
| 07/04/1989 | CA1256803A1 Pharmaceutical formulation containing azapropazone |
| 07/04/1989 | CA1256800A1 Whipped gel composition |
| 07/04/1989 | CA1256798A1 System for administration of liposomes to mammals |
| 07/04/1989 | CA1256796A1 Cytotoxic conjugates which can be used in therapy and process for their preparation |
| 06/29/1989 | WO1989005824A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
| 06/29/1989 | WO1989005816A1 Cellular toxic conjugates |
| 06/29/1989 | WO1989005660A1 Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis |
| 06/29/1989 | WO1989005646A1 Uses of sulphated sugars |
| 06/29/1989 | WO1989005645A1 Use of sucralfate |
| 06/29/1989 | WO1989005640A1 Pharmaceutical compositions |
| 06/29/1989 | WO1989005635A1 A method for the preparation of coated solid medicament form |
| 06/29/1989 | WO1989005632A1 Porous microspheres for drug delivery and methods for making same |
| 06/28/1989 | EP0322393A1 New beta-1,3-glucan exopolysaccharide and process for its preparation |
| 06/28/1989 | EP0322277A1 Sustained release pharmaceutical composition |
| 06/28/1989 | EP0322222A1 Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
| 06/28/1989 | EP0322197A1 New dithranol compositions |
| 06/28/1989 | EP0322137A1 Spray dried ibuprofen |
| 06/28/1989 | EP0322048A1 Pharmaceutical compositions |
| 06/28/1989 | EP0321870A1 Skin penetration enhancement using free base and acid addition salt combinations of active agents |
| 06/28/1989 | EP0321786A2 Composition for external application |
| 06/28/1989 | EP0321636A2 Enhancers for the transdermal flux of certain 1,4-Dihydropyridine derivatives |
| 06/28/1989 | EP0321548A1 Novel amphiphilic nucleic acid conjugates |
| 06/28/1989 | EP0321499A1 Covalently bonded active agents with carbonium ion base groups. |
| 06/28/1989 | EP0321474A1 Water soluble complex of a poly(vinylpyrrolidone) copolymer and d-threo-(1,1'-dihydroxy-1-p-nitrophenylisopropyl) dichloroacetamide |
| 06/28/1989 | EP0321464A1 Coatings based on polydextrose for aqueous film coating of pharmaceutical, food and confectionery products |
| 06/28/1989 | EP0152366B1 Compositions for therapeutic use comprising organo-silicon compounds |
| 06/27/1989 | US4843096 Nonaqueous gel of 13-cis-retinoic acid |
| 06/27/1989 | US4842868 Controlled release of drugs, insecticides |
| 06/27/1989 | US4842865 Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules |
| 06/27/1989 | US4842864 Self-adhesive device for the percutaneous administration of an active ingredient |
| 06/27/1989 | US4842856 Parenteral solution |
| 06/27/1989 | CA1256376A1 Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo¬2,-1- b|thiazole |
| 06/27/1989 | CA1256374A1 Bromocriptine compositions |
| 06/27/1989 | CA1256373A1 Laxative composition based on lactulose and its preparation process |
| 06/21/1989 | EP0321369A1 Heterocyclic sweeteners derived from N-carbamoyl-, N-thiocarbamoyl or N-amidino-glycine or beta-alanine |
| 06/21/1989 | EP0321368A1 Heterocyclic N-carbamoyl, N-thiocarbamoyl or N-amidino-aminomalonyl or -aminosuccinyl amide derivatives as sweetening agents |
| 06/21/1989 | EP0321231A1 Pharmaceutical compositions |
| 06/21/1989 | EP0320550A1 Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent |
| 06/21/1989 | EP0320528A1 Use of hemocyanins and arylphorins for influencing the immune system and the treatment of tumors |
| 06/20/1989 | US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance |
| 06/20/1989 | US4840938 Pharmaceutical compositions containing anthracycline glycosides |
| 06/20/1989 | US4840937 Surfactant composed of acylated collagen or acylated gelatine and a production process thereof |
| 06/20/1989 | US4840797 Confectionery or pharmaceutical product with a sugarless coating obtained by hard coating and method for its preparation |
| 06/20/1989 | CA1256250A1 Covalently-modified neutral bacterial poly- saccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates |
| 06/20/1989 | CA1256237A1 Substance for the preparation of plastic and/or hard substances for dental-technical, (dental)medical and related purposes, process for its production and the use thereof |
| 06/20/1989 | CA1256030A1 Composition for ophthalmological use |
| 06/15/1989 | WO1989005347A1 Method to solubilize tissue plasminogen activator |
| 06/15/1989 | WO1989005319A1 Hydrophilic polyurethanes of improved strength |
| 06/15/1989 | WO1989005158A1 Low ph pharmaceutical compositions of recombinant beta-interferon |
| 06/15/1989 | WO1989005151A1 High integrity liposomes and method of preration and use |
| 06/15/1989 | WO1989005149A1 Methyl cellulose pharmaceutical composition |
| 06/15/1989 | WO1989005140A1 Tumour-targeting agents and a method of targeting tumours |
| 06/15/1989 | DE3840076A1 Injectable solution of the thioctic acid salt with trometamol and/or basic amino acids |
| 06/14/1989 | EP0320254A1 Aqueous gels containing topical medicaments |
| 06/14/1989 | EP0320097A1 Controlled absorption diltiazem formulations |
| 06/14/1989 | EP0320051A1 Controlled release combination of carbidopa/levodopa |
| 06/14/1989 | EP0319988A1 External dermatological composition |
| 06/14/1989 | EP0319965A1 Pharmaceutical preparation for tinea pedis |
| 06/14/1989 | EP0319963A1 Preparations of vitamin E for external use |
| 06/14/1989 | EP0319902A2 Transdermal Absorptive drug formulation |
| 06/14/1989 | EP0319856A2 Antibiotic composition containing cephalosporin |
| 06/14/1989 | EP0319638A1 Liposome containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions |
| 06/14/1989 | EP0319598A1 Stabilized aqueous preparation of folic acid |
| 06/14/1989 | EP0142561B1 Long-acting nifedipine preparation |
| 06/13/1989 | US4839389 Treatment of diseases caused by human or animal immunodeficiency; effective against infectious diseases; escherichia |
| 06/13/1989 | US4839345 Reaction product of protein and n-hydroxyimidoester |
| 06/13/1989 | US4839341 Stabilized insulin formulations |
| 06/13/1989 | US4839179 Preparation of a composition based on a finely divided active principle of low water solubility |
| 06/13/1989 | US4839176 Therapeutic agents |
| 06/13/1989 | US4839170 Administering methylamine, hydroxylamine or the nontoxic hydrochlorides intramuscularly |
| 06/13/1989 | EP0305384A4 Water soluble polyvinyl lactam-drug complexes. |
| 06/13/1989 | EP0246307A4 Cys codon-modified dna. |
| 06/13/1989 | CA1255597A1 Solid medicament formulations containing dihydropyridines and a process for their preparation |
| 06/13/1989 | CA1255594A1 Compositions and methods of enhancing transdermal and transmembrane penetration of topical and systemic agents |
| 06/13/1989 | CA1255590A1 Therapeutical preparations comprising organo-silicon compositions |
| 06/07/1989 | EP0319253A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 06/07/1989 | EP0319126A2 Process for preparation of polyol fatty acid ester and glyceride mixture obtained |
| 06/07/1989 | EP0319074A1 Pharmaceutical composition and process for its preparation |
| 06/07/1989 | EP0318948A2 Cleavable immunoconjugates for the delivery and release of agents in native form |
| 06/07/1989 | EP0318906A1 Lyophilized preparation of platinum compound |
| 06/07/1989 | EP0318891A1 Injectable solution of thioctic acid containing trometamole and/or basic amino acids |
| 06/07/1989 | EP0318801A2 Preparation to prevent adhesion of organs and organ parts |
| 06/07/1989 | EP0318567A1 ''meso-lactide'' and process for manufacturing it. |
| 06/07/1989 | EP0318522A1 Anti-inflammatory cream composition |
| 06/07/1989 | EP0318512A1 Delivery systems for pharmacological agents |